Scancell (LON:SCLP) Trading Down 8.9% – Should You Sell?

Scancell Holdings plc (LON:SCLP)’s share price dropped 8.9% during trading on Monday . The company traded as low as GBX 7.72 ($0.10) and last traded at GBX 7.72 ($0.10). Approximately 395,448 shares traded hands during mid-day trading, a decline of 51% from the average daily volume of 801,264 shares. The stock had previously closed at GBX 8.47 ($0.11).

Scancell Trading Up 2.2 %

The business has a fifty day moving average of GBX 8.88 and a 200-day moving average of GBX 11.65. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The company has a market capitalization of £83.07 million, a P/E ratio of -12.30 and a beta of 0.35.

Scancell (LON:SCLP) last released its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. Analysts anticipate that Scancell Holdings plc will post -2.5361112 earnings per share for the current fiscal year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.